Review, 2024

New government drug repurposing programs: Opportunities and uncertainties

SCIENCE TRANSLATIONAL MEDICINE, ISSN 1946-6234, Volume 16, 753, 10.1126/scitranslmed.adl0998

Contributors

Liddicoat, Johnathon (Corresponding author) [1] [2] Hamidzadeh, Ashleigh [1] [2] Liddell, Kathleen [3] Schito, M [4] Simon, David [5] Aboy, Mateo [3] Minssen, Timo 0000-0002-3286-4888 [6]

Affiliations

  1. [1] Kings Coll London, Dickson Poon Sch Law, London WC2R 2LS, England
    2. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  2. [2] Kings Coll London, Dickson Poon Sch Law, London WC2R 2LS, England
    3. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  3. [3] Univ Cambridge, Fac Law, Cambridge CB3 9DZ, England
    4. [NORA names: United Kingdom; Europe, Non-EU; OECD];
  4. [4] Univ Arizona, James E Rogers Coll Law, Tucson, AZ 85721 USA
    5. [NORA names: United States; America, North; OECD];
  5. [5] Northeastern Univ, Sch Law, Boston, MA 02115 USA
    6. [NORA names: United States; America, North; OECD];

Abstract

Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.

Data Provider: Clarivate

LINKS
-

Matching Records in NORA

SUBJECTS
+

METRICS
+